Cepheida receives approval for its bacterial diagnostic test
Molecular-diagnostic company Cepheid has received the Food and Drug Administration (FDA) approval for a test that helps in rapid diagnosis of a bacteria linked to antibiotic-resistant infections. Cepheid’s Xpert C.difficile test can detect within 45 minutes a bacterium that causes the Clostridium difficile infection, resulting in diarrhea and more serious intestinal conditions, such as colitis.
- InfraScan receives CE Mark for handheld detector
- Quidel receives CLIA waiver for QuickVue RSV test
- GE Healthcare receives FDA nod for high-definition computed tomography scanner
- Obetech develops diagnostic test for obesity virus
